Christofi, MariaLe Sommer, S.Moelzer, ChristineKlaska, I. P.Kuffova, LForrester, J V2021-04-082021-04-082021-03Christofi, M, Le Sommer, S, Moelzer, C, Klaska, I P, Kuffova, L & Forrester, J V 2021, 'Low-dose 2-Deoxy Glucose Stabilises Tolerogenic Dendritic Cells and Generates Potent in vivo Immunosuppressive Effects', Cellular and Molecular Life Sciences, vol. 78, no. 6, pp. 2857-2876. https://doi.org/10.1007/s00018-020-03672-y1420-682XORCID: /0000-0002-8015-7774/work/83311010ORCID: /0000-0003-3301-7397/work/83311209https://hdl.handle.net/2164/16206Open Access via Springer Compact Agreement University of Aberdeen Development Trust Grant number RG14251, RG12663 Acknowledgements: We thank the University of Aberdeen Iain Fraser Flow Cytometry core facility, and the University of Aberdeen Histology and Microscopy core facility for processing of histology slides. The authors thank University of Aberdeen Medical Research Facility for technical assistance with in vivo experiments. We thank Dr. Tian Yu, Dr. Yi-Hsia Liu, Mrs Rosemary Fordyce, and Mrs Elizabeth Muckersie for technical assistance with in vivo and in vitro experiments. Funding: This work was supported by funds from the University of Aberdeen Development Trust Grants RG14251 and RG12663. Maria Christof was the recipient of a University of Aberdeen PhD Studentship. Samantha Le Sommer was funded by a Wellcome Trust ISSF Postdoctoral Fellowship.204881168engAutoimmunityCell therapyMetabolic programmingToleranceZbtb46RHEUMATOID-ARTHRITISACTIVATIONHOMEOSTASISMACROPHAGEEXPERIMENTAL AUTOIMMUNE UVEORETINITISSIRP-ALPHAINHIBITIONIMMUNOTHERAPYSTEADY-STATET-CELLSR MedicineCellular and Molecular NeuroscienceMolecular MedicineMolecular BiologyCell BiologyPharmacologyOtherRG12663RG14251Supplementary DataRJournal article10.1007/s00018-020-03672-yhttp://www.scopus.com/inward/record.url?scp=85092688822&partnerID=8YFLogxK786